"Die DKD HELIOS Klinik Wiesbaden ist ein Haus mit 112 Betten, 60 tagesklinischen Plätzen, angesiedelten Praxen und einem Medizinischen Versorgungszentrum (MVZ) für Patienten aller Kassen. Die DKD HELIOS Klinik Wiesbaden bündelt die fachübergreifende Kompetenz verschiedener Fachbereiche und Zentren für z. B. Schilddrüsenerkrankungen, Beckenbodenerkrankungen, Erkrankungen der weiblichen Brust, Gefäßkrankheiten, Herz- und Lungenerkrankungen und Bewegungsstörungen."

During the past decade, Deutsche Klinik für Diagnostik conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Deutsche Klinik für Diagnostik" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials, followed by "Mitsubishi Tanabe Pharma America Inc." with 3 trials sponsored, "University Hospital Tuebingen" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "European Society for Blood and Marrow Transplantation" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Deutsche Klinik für Diagnostik" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "CHUGAI sanofi-aventis" with 1 trials as a collaborator, "Deutsche Klinik fuer Diagnostik" with 1 trials as a collaborator, "University Hospital Carl Gustav Carus" with 1 trials as a collaborator and "University Hospital Dresden" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Deutsche Klinik für Diagnostik" are "Chronic Lymphocytic Leukemia" (3 trials), "Lymphoma" (3 trials), "ALS" (2 trials), "Acute Myeloid Leukemia" (2 trials) and "Complications" (2 trials). Many other conditions were trialed in "Deutsche Klinik für Diagnostik" in a lesser frequency.

Most popular intervention types in "Deutsche Klinik für Diagnostik" are "Drug" (25 trials), "Procedure" (9 trials), "Biological" (6 trials), "Radiation" (5 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "radiation therapy" (5 trials), "Capnography" (4 trials), "filgrastim" (4 trials) and "MT-1186" (3 trials). Other intervention names were less common.

The vast majority of trials in "Deutsche Klinik für Diagnostik" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Deutsche Klinik für Diagnostik". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Deutsche Klinik für Diagnostik, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Deutsche Klinik für Diagnostik, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Deutsche Klinik für Diagnostik has several departments that took part in Clinical trials: "Deutsche Klinik für Diagnostik; DKD Helios Klinik Wiesbaden, Abt. Neurologie" - 6 trials